Can Down Syndrome Be Screened During IVF in Georgia?
Direct answer: Yes. Reproductive centers in Georgia widely perform Preimplantation Genetic Testing for Aneuploidy (PGT-A). This technology can screen embryos for trisomy 21 (Down syndrome). However, screening results are influenced by factors such as biopsy technique, embryo quality, and mosaicism ratio, and are not absolute. The following details are explained from a physician's perspective.
Why is Screening for Down Syndrome Necessary?
Down syndrome (trisomy 21) is the most common chromosomal numerical abnormality, with its incidence significantly increasing with maternal age. The risk is approximately 1 in 1500 for a 20-year-old woman, 1 in 350 at age 35, and 1 in 100 at age 40. The primary cause is the non-disjunction of chromosome 21 during oocyte meiosis. Through PGT-A, euploid (normal chromosome number) and aneuploid embryos can be identified before transfer, thereby avoiding the transfer of trisomy 21 embryos.
Process of PGT-A Screening in Georgia
| Step | Details | Timeline |
|---|---|---|
| 1. Ovarian Stimulation & Egg Retrieval | The woman uses ovulation induction medications, monitored by ultrasound until follicle maturity, then eggs are retrieved. | Starting from day 2-3 of menstruation, cycle lasts about 10-14 days. |
| 2. Fertilization & Embryo Culture | ICSI or conventional IVF fertilization, culture to blastocyst stage on day 5-6. | 5-6 days after egg retrieval. |
| 3. Trophectoderm Biopsy | 3-5 cells are taken from the trophectoderm of the blastocyst. | After blastocyst formation. |
| 4. Genetic Analysis | NGS or aCGH is used to detect chromosomal aneuploidies. | 7-14 days after biopsy. |
| 5. Embryo Freezing & Transfer | Select euploid embryos for freezing, thaw and transfer during the window period. | Usually in the next cycle. |
Physician's Perspective: The Value of PGT-A for Down Syndrome Screening
Reproductive physicians practicing in Georgia consider PGT-A the most effective preemptive method currently available for screening Down syndrome. However, several points need clarification:
- PGT-A tests cells from the trophectoderm, which may differ from the inner cell mass (which develops into the fetus) due to mosaicism, with a false negative rate of approximately 1-2%.
- PGT-A cannot detect structural chromosomal abnormalities (e.g., Down syndrome caused by translocations). PGT-SR is required for concurrent structural abnormality screening.
- PGT-A does not replace amniocentesis during pregnancy. After transferring a euploid embryo, non-invasive DNA testing or amniocentesis in the second trimester is still recommended for confirmation.
Easily Overlooked Details: Mosaicism and Biopsy Timing
Many patients assume PGT-A results are absolute. In reality, embryos can exhibit mosaicism—some cells have normal chromosomes, others abnormal. If the biopsy happens to sample normal cells while the inner cell mass is abnormal, a false negative can occur. Some centers in Georgia use blastocyst-stage trophectoderm biopsy (day 5-6), which has a lower misdiagnosis rate for mosaicism compared to cleavage-stage biopsy (day 3). Additionally, laboratory quality control (e.g., NGS depth) affects sensitivity. It is advisable to choose centers with PGT-A experience that provide classification reports for mosaic embryos.
Differences Between Countries: Georgia vs. China
- Policy: In China, PGT-A requires medical indications (e.g., advanced maternal age, chromosomal abnormalities, recurrent miscarriage). In Georgia, there are no restrictions; it can be requested based on personal preference.
- Cost: The cost of PGT-A in Georgia is approximately $3,000-$5,000 (biopsy + testing for one cycle). In China, similar services cost about 20,000-40,000 RMB (some not covered by insurance).
- Waiting Time: In Georgia, cycle coordination is fast with no waiting list. In China, approval processes are needed, with a wait of about 1-3 months.
- Embryo Freezing: In Georgia, vitrification is commonly used, with a survival rate over 95%, supporting multiple transfer attempts.
Frequently Asked Questions
Q: How accurate is PGT-A for Down syndrome?
A: For whole chromosome numerical abnormalities (e.g., trisomy 21), the detection rate of PGT-A exceeds 99% (excluding mosaicism factors). False negatives mainly arise from mosaicism or contamination of biopsied cells.
Q: If my embryo's PGT-A result says "mosaic trisomy 21 10%", can it be transferred?
A: It depends on the mosaicism percentage and the center's policy. Some centers in Georgia allow the transfer of low-percentage (<30%) mosaic embryos, but pre-transfer genetic counseling is required, and amniocentesis must be performed after transfer.
Q: Which hospitals in Georgia can perform PGT-A?
A: Major reproductive centers in Tbilisi (such as JSC "In Vitro", Beta Clinic, Chachava, etc.) have collaborating genetic testing laboratories. It is recommended to choose centers certified by the European Society of Human Reproduction and Embryology (ESHRE) or supported by international independent laboratories.
Practitioner Observations: Common Misconceptions About Down Syndrome Screening
- Misconception 1: "If PGT-A has screened for Down syndrome, there is no need for NT scan or NIPT during pregnancy." — Incorrect. PGT-A screens the embryo, not the mother. Routine prenatal checkups are still necessary.
- Misconception 2: "Having third-generation IVF guarantees avoiding a baby with Down syndrome." — Incorrect. PGT-A still has a false negative rate, and factors like twins, advanced maternal age, or poor ovarian response may result in no detectable embryos.
- Misconception 3: "IVF in Georgia can screen for all genetic diseases." — Incorrect. PGT-A only detects chromosomal numerical abnormalities and large structural anomalies. Monogenic diseases require PGT-M, which has different costs and procedures.
What to Prepare for the Actual Process
- Karyotype analysis for both partners (to rule out balanced translocation carriers).
- Female: AMH, sex hormone panel, antral follicle count (to assess ovarian reserve).
- Male: Semen analysis (including DFI).
- Infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis, etc.).
- Passport valid for at least 6 months.
- If PGT-M (for monogenic disease) is needed, family verification must be completed first.
How Long Does It Take? Timeline
From the initial consultation to obtaining PGT-A results and transfer, it typically takes 2-3 months. Specifically:
- Initial consultation + tests: 2-4 weeks (some tests can be done in China or Georgia).
- Cycle start (stimulation) + egg retrieval: 2-3 weeks.
- Embryo culture + biopsy + testing: 4-6 weeks (including testing period).
- Transfer cycle: If the endometrium is ready after results, transfer can occur the same month; otherwise, it may take 1-2 months.
Risk Reminder
PGT-A is an invasive procedure (embryo biopsy) with a 0.5-1% risk of damaging the embryo. Additionally, about 10-15% of blastocysts may not yield a report due to failure to meet testing requirements or complex chromosomal abnormalities. When choosing a center in Georgia, ensure it has an independent molecular genetics laboratory and provides pre-transfer counseling. The final decision on transfer should combine the physician's advice and your own circumstances.
Physician's Advice: If one partner has Down syndrome (extremely rare) or carries a Robertsonian translocation leading to a very high risk of trisomy 21, PGT-SR (structural rearrangement testing) should be prioritized over standard PGT-A. For patients with advanced maternal age or a history of trisomy 21 pregnancy, PGT-A is a reasonable choice. Regardless of the results after transfer, standard prenatal screening and diagnosis must be completed.
Comments (0)